Your institution may have access to this item. Find your institution then sign in to continue.
Title
Daclizumab use in patients with pediatric multiple sclerosis.
Authors
Gorman, Mark P; Tillema, Jan-Mendelt; Ciliax, Annika M; Guttmann, Charles R G; Chitnis, Tanuja
Abstract
Daclizumab, a humanized monoclonal antibody specific for the interleukin 2 receptor α chain, reduces clinical and magnetic resonance imaging disease activity in patients with adult-onset multiple sclerosis (MS) as monotherapy or add-on therapy with interferon.